US PATENT SUBCLASS 424 / 143.1
.~.~ Binds receptor

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

130.1  DF  IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL {18}
141.1  DF  .~ Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) {8}
143.1.~.~ Binds receptor {1}
144.1  DF  .~.~.~> Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., NK cell, etc.)

DEFINITION

Classification: 424/143.1

Binds receptor:

(under subclass 141.1) Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a free or cell-associated receptor.

(1) Note. A receptor is a structure integral to a cell, or released into the surrounding milieu, that has binding specificity for a particular three-dimensional structural configuration of a molecule or portion thereof.

(2) Note. For the purpose of this and the indented subclass, an antibody is not considered a receptor. Patents disclosing non-anti-idiotypic monoclonal antibodies or fragments thereof that bind other immunoglobulins are proper for subclass 145.1, unless the monoclonal antibodies specifically bind hematopoietic-cell-bound immunoglobulins, in which case, the patents are proper for subclass 153.1.